Key statistics
As of last trade, Abcellera Biologics Inc (8QQ:HAM) traded at 3.02, 77.42% above the 52 week low of 1.70 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.89 |
|---|---|
| High | 3.02 |
| Low | 2.89 |
| Bid | 3.14 |
| Offer | 3.18 |
| Previous close | 2.87 |
| Average volume | 1.41k |
|---|---|
| Shares outstanding | 303.16m |
| Free float | 234.39m |
| P/E (TTM) | -- |
| Market cap | 1.09bn USD |
| EPS (TTM) | -0.4905 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 16:25 GMT.
More ▼
Press releases
- AbCellera Reports Full Year 2025 Business Results
- AbCellera to Present at Upcoming Investor Conferences in March and April 2026
- AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
- AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
- AbCellera and Bruker Reach Global Settlement of Patent Litigation
- AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
More ▼
